Reuters logo
BRIEF-Bristol-Myers Squibb posts data from trials evaluating Opdivo, Yervoy regimen
2016年6月6日 / 上午11点12分 / 1 年前

BRIEF-Bristol-Myers Squibb posts data from trials evaluating Opdivo, Yervoy regimen

June 6 (Reuters) - Bristol-Myers Squibb Co :

* Bristol-Myers Squibb -long-term data from two trials evaluating opdivo and yervoy regimen in advanced melanoma continues to validate co’s immuno-oncology combination approach Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below